Astrazeneca is on a roll today. The stock surged over 7% to an intra day high at Rs.1245.75 and volumes are also pretty robust, rising over 2 times to some 13,000 shares.

The stock is in the limelight following its turnaround performance for Q3FY16. The company posted a net profit of Rs.7 crore, compared to loss Rs.7 crore (QoQ) and loss of Rs.13 crore in Q3FY15. This was on the back of a very good growth in topline at Rs.144 crore, up 34% (YoY).